首页> 外国专利> USE OF NADPH OXIDASE INHIBITOR IN PRODUCTION OF MEDICAMENT FOR PREVENTING ATHEROSCLEROSIS

USE OF NADPH OXIDASE INHIBITOR IN PRODUCTION OF MEDICAMENT FOR PREVENTING ATHEROSCLEROSIS

机译:NADPH氧化酶抑制剂在生产预防动脉粥样硬化的药物中的用途

摘要

PPROBLEM TO BE SOLVED: To provide a method for preventing and treating the initial state of atherosclerosis and its related disease in a mammal. PSOLUTION: This method involves administering an NADPH oxidase inhibitor such as apocynin. The NADPH oxidase inhibitor such as the apocynin inhibits p47[SBphox/SB] from translocating to an endothelial cell gp91[SBphox/SB] and a p22[SBphox/SB]- bonding NADPH oxidase component, and as a result, LDL is prevented from being accumulated in a space of a subendothelial layer caused by the high permeability of the endothelium. PCOPYRIGHT: (C)2003,JPO
机译:<要解决的问题:提供一种预防和治疗哺乳动物动脉粥样硬化及其相关疾病的初始状态的方法。

解决方案:此方法涉及施用NADPH氧化酶抑制剂(如载脂蛋白)。 NADPH氧化酶抑制剂(如载脂蛋白)可抑制p47 [ phox ]转移至内皮细胞gp91 [ phox ]和p22 [ phox ] -结合NADPH氧化酶组分,结果,防止了LDL由于内皮的高渗透性而积累在内皮下层的空间中。

版权:(C)2003,日本特许厅

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号